Skip to content

Metabolomics

Biosfer Teslab obtains a grant from ICEX Next programme

ICEX Next internationalisation programme The ICEX Next programme aims to promote the internationalisation of Spanish companies and their confidence in foreign markets. The ICEX Internationalization programme, aims to help and internationalize the business, in order to increase turnover abroad, reduce business risk and increase global competitiveness. The programme, aimed at any Spanish SME that has… Read More »Biosfer Teslab obtains a grant from ICEX Next programme

ICEX Next

Biosfer Teslab present at the Metabolomics 2022 congress

Biosfer Teslab presents at Metabolomics 2022 The 18th Annual Conference of the Metabolomics Society – Metabolomics 2022 took place in Valencia from 19 to 23 June. The event brought together hundreds of scientists from around the world who presented the latest technological and bioinformatics advances in the field of metabolomics, as well as its application… Read More »Biosfer Teslab present at the Metabolomics 2022 congress

biosfer Teslab en metabolomics

Biosfer Teslab Award for Innovation and Digitalisation Tarragona 2022

Innovation and Digitalisation Award 2022 Tarragona In recognition of the great work carried out by small and medium-sized enterprises as generators of wealth and creators of employment in the performance of their daily work, Banco Santander, Cámara de Comercio de Tarragona and the Cámara de Comercio de Reus, in collaboration with the Cámara de España… Read More »Biosfer Teslab Award for Innovation and Digitalisation Tarragona 2022

premio innovación

Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing

Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing together with 5 other start-ups in the sector organized by Telefonica Open Future. Last year, Biosfer Teslab was selected to participate in the Tarragona Open Future where it was awarded with the second place. Open… Read More »Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing

Biosfer Teslab invitada en el primer Futurecamp Open Future

Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine… Read More »Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

Metabolòmica al the Liver meeting

Early molecular signature of Parkinson and dementia years before the diseases appear

NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the… Read More »Early molecular signature of Parkinson and dementia years before the diseases appear

Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia

Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate the role of plasma metabolomics in atherosclerosis according to the presence of type 1 diabetes (T1D) or previous preeclampsia. They have concluded that plasma metabolomics… Read More »Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia